Musculo-Skeletal-Disorders Osteoarthritis

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Osteoarthritis Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Osteoarthritis Projects
--ALFA WASSERMANN S.p.A.
--Abiogen Pharma S.p.A.
--Amgen Inc
--Alpharma Inc
--Eli Lilly & Co
--Dainippon Sumitomo Pharma Co., Ltd.
--Genzyme Corporation
--Emisphere Technologies Inc
--IDEA AG
--Glenmark Pharmaceuticals Limited
--NicOx S.A.
--Jerini AG
--Paladin Labs Inc.
--Novartis AG
--Seikagaku Corporation
--Pfizer Inc
--Winston Laboratories, Inc.
--Taisho Pharmaceutical Co., Ltd.
--ZARS Pharma
--Wyeth

--Top Companies in early stage Osteoarthritis Projects
--AnGes MG, Inc.
--Amgen Inc
--AP Pharma Inc
--Antares Pharma Inc
--C&O Pharmaceutical Technology
--ings) Limited
--AstraZeneca Plc
--Echo Therapeutics, Inc
--Dr Reddys Laboratories Ltd
--GlaxoSmithKline plc
--Geron Corporation
--LeukoMed, Inc.
--KAKEN PHARMACEUTICAL CO., LTD.
--Roche Holdings Ltd
--Pharmos Corporation
--Santen Pharmaceutical Co., Ltd.
--Rottapharm SpA
--Shionogi & Co., Ltd.
--Scil Technology GmbH
--XOMA Ltd
--Wyeth

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View